Levodopa therapeutics for Parkinson's disease: new developments.

Levodopa therapeutics for Parkinson's disease: new developments.

Item
http://www.wikidata.org/entity/Q37364832
Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations.Formulation optimization of a palm-based nanoemulsion system containing levodopa.24-Epibrassinolide, a Phytosterol from the Brassinosteroid Family, Protects Dopaminergic Cells against MPP-Induced Oxidative Stress and Apoptosis.Absolute Bioavailability and Effect of Food on the Disposition of Safinamide Immediate Release Tablets in Healthy Adult Subjects.Release behaviour and toxicity evaluation of levodopa from carboxylated single-walled carbon nanotubes.Long-Term Effects of Safinamide on Dyskinesia in Mid- to Late-Stage Parkinson's Disease: A Post-Hoc Analysis.Aspergillus niger PA2: a novel strain for extracellular biotransformation of L-tyrosine into L-DOPA.Transcranial Direct Current Stimulation Ameliorates Behavioral Deficits and Reduces Oxidative Stress in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Mouse Model of Parkinson's Disease.Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease.Pressor response to oral tyramine during co-administration with safinamide in healthy volunteers.Incorporation of Levodopa into Biopolymer Coatings Based on Carboxylated Carbon Nanotubes for pH-Dependent Sustained Release Drug Delivery.
P2860

Levodopa therapeutics for Parkinson's disease: new developments.

Item
http://www.wikidata.org/entity/Q37364832
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Levodopa therapeutics for Parkinson's disease: new developments.
@en
Levodopa therapeutics for Parkinson's disease: new developments.
@nl
type
label
Levodopa therapeutics for Parkinson's disease: new developments.
@en
Levodopa therapeutics for Parkinson's disease: new developments.
@nl
prefLabel
Levodopa therapeutics for Parkinson's disease: new developments.
@en
Levodopa therapeutics for Parkinson's disease: new developments.
@nl
P1433
P1476
P2093
P304
P31
P356
P4011
P478
P577
P698
P921
P356
P1433
P1476
Levodopa therapeutics for Parkinson's disease: new developments.
@en
P2093
P304
P31
P356
10.1016/S1353-8020(09)70009-4
P4011
f823470322f3a1ddca3ed86c0bbbad802b95b296
P478
P577
P698
P921